Oncogene-induced DNA replication stress contributes critically to the genomic instability that is present in cancer 1-4 . However, elucidating how oncogenes deregulate DNA replication has been impeded by difficulty in mapping replication initiation sites on the human genome. Here, using a sensitive assay to monitor nascent DNA synthesis in early S phase, we identified thousands of replication initiation sites in cells before and after induction of the oncogenes CCNE1 and MYC. Remarkably, both oncogenes induced firing of a novel set of DNA replication origins that mapped within highly transcribed genes. These ectopic origins were normally suppressed by transcription during G1, but precocious entry into S phase, before all genic regions had been transcribed, allowed firing of origins within genes in cells with activated oncogenes. Forks from oncogene-induced origins were prone to collapse, as a result of conflicts between replication and transcription, and were associated with DNA double-stranded break formation and chromosomal rearrangement breakpoints both in our experimental system and in a large cohort of human cancers. Thus, firing of intragenic origins caused by premature S phase entry represents a mechanism of oncogene-induced DNA replication stress that is relevant for genomic instability in human cancer.
; n = 3 independent experiments; grey symbols, individual data points) at the indicated times after mitotic shake-off. OE, overexpression of cyclin E; NE, normal levels of cyclin E. b, Replication initiation profiles (EdUseq-HU) at a representative genomic region in OE and NE cells collected 6 and 14 h after mitotic shake-off, respectively. RT, replication timing (blue, early; green, mid; yellow, late S phase); Ge, genes (green, forward direction of transcription; red, reverse; yellow, unspecified; blue, multiple genes within bin); iG, intergenic (grey). Bin resolution, 10 kb; ruler scale, 100 kb; σ, sigma (normalized number of sequence reads per bin divided by its s.d.).
c, Classification of origins based on adjusted σ value ratios in OE over NE cells: CN, constitutive (less than twofold induction); Oi2, oncogene-induced 2 (more than twofold induction); Oi, oncogene-induced (more than fourfold induction). d, e, Distribution of CN, Oi2 and Oi origins according to RT (d) and gene annotation (e) (All-RT, all RT domains; E-RT, early S phase RT genomic domains). f, g, Replication initiation profiles (EdUseq-HU) at a representative genomic region (f) and scatter plots of EdUseq-HU values at all origins (g) in NE and OE cells at the indicated times after mitotic shakeoff. h, Replication initiation profiles (EdUseq-noHU) at a representative genomic region in OE and NE cells. EdU was present during the indicated times following mitotic shake-off.
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shortage of replication factors, reduced fork elongation rates, increased transcription and replication-transcription conflict [5] [6] [7] [8] [9] [10] [11] [12] [13] . However, to our knowledge, no study has yet mapped genome-wide DNA replication and transcription in cells, before and after oncogene activation, which could provide important insights into oncogene-induced DNA replication stress. We studied U2OS human cell lines, in which inducible activation of either of the proto-oncogenes CCNE1 (cyclin E) or MYC leads to DNA replication stress 6, [13] [14] [15] . Amplifications of the CCNE1 and MYC genes are among the most frequent genetic changes in human cancers [2] [3] [4] . We first focused on the cyclin E system. As previously shown 5, 14, 16 , overexpression of cyclin E shortened the length of the G1 cell cycle phase, from about 10-12 h for cells with normal cyclin E activity, to as little as 2-4 h ( Fig. 1a and Extended Data Fig. 1 ). To examine DNA replication initiation (origin firing), cells with normal levels of cyclin E and cells overexpressing cyclin E were collected by mitotic shake-off and allowed to proceed through the cell cycle in the presence of 5-ethynyl-2′ -deoxyuridine (EdU) and hydroxyurea (HU) [17] [18] [19] . EdU-labelled DNA was isolated and subjected to high-throughput sequencing (EdUseq-HU; Extended Data Fig. 1b, c) . The data, analysed at a genomic bin resolution of 10 kb, yielded well-resolved peaks, corresponding to the regions where DNA replication initiated ( Fig. 1b and Supplementary Table 1 ). Of 6,164 identified peaks, 927 were induced strongly (at least fourfold) in cyclin E-overexpressing cells and will be referred to as oncogene-induced (Oi) origins; 1,281 were induced modestly by cyclin E overexpression and will be referred to as Oi2 origins; and 3,956 were of similar magnitude in the normal and cyclin E-overexpressing cells and will be referred to as constitutive origins (Fig. 1b, c) .
To determine whether constitutive and Oi origins were qualitatively different, we examined their genomic distribution in relation to replication timing and gene annotation. Early, mid and late S phase replicating domains were mapped by REPLIseq 20 (Extended Data Fig. 2) . The constitutive origins were present exclusively in early S domains, as expected of cells that had just entered S phase, whereas the Oi origins exhibited a broader distribution that encompassed both early and mid S domains (Fig. 1d ). In regard to gene annotation, while the constitutive origins mapped predominantly to intergenic regions, a substantial fraction of the Oi origins, particularly those in early S domains, mapped within protein-coding genes (Fig. 1e ). Similar results were obtained when the resolution of origin mapping was increased from 10 kb to 1 kb by treating the cells with mimosine or aphidicolin, in addition to hydroxyurea, to more robustly arrest fork progression after origin firing (Extended Data Fig. 3 and Supplementary Table 2 ).
We examined origin firing at multiple time points after mitotic exit in cyclin E-overexpressing cells, and found that Oi origins fired predominantly in the cells with the shortest G1 phases (less than 6 h; Fig. 1f , g and Supplementary Table 3 ). As expected, origin firing was not observed before S phase entry (that is, within the first 2 h after mitotic exit). Furthermore, the Oi origins initiated DNA replication even in the absence of hydroxyurea, indicating that they were not dormant origins ( Fig. 1h and Extended Data Fig. 3f ). Thus, oncogene activation Letter reSeArCH led to the firing of novel replication origins within genomic domains normally devoid of replication initiation in cells that entered S phase prematurely.
The aberrant firing of intragenic Oi origins could be related to deregulation of transcription, but the newly synthesized transcript profiles (EUseq) of cells examined at multiple time points after mitotic exit showed that cyclin E overexpression did not affect transcription genome-wide ( Fig. 2a and Extended Data Fig. 4a ) or at the genomic sites where the Oi origins fired ( Fig. 2b and Extended Data Fig. 3e ). Notably, whereas the constitutive origins, including the genic ones, mapped to non-transcribed or weakly transcribed regions, the genic Oi origins mapped to sites that were highly transcribed at all time points examined, except for the early time point of 2 h after mitotic exit ( Fig. 2b and Extended Data Fig. 3e ). Thus, replication at the sites of Oi origins may initiate before these sites are transcribed. Indeed, specific examples ( Fig. 2c ) and averages of transcription and replication along large genes ( Fig. 2d and Extended Data Fig. 4b ) revealed that, 2 h after mitotic exit, the transcription wave front had not yet reached the 3′ ends of genes, where most of the Oi origins were located.
Transcription has been proposed to inactivate intragenic origins before S phase entry 21, 22 . Thus, one interpretation of our results is that intragenic origins fired upon oncogene-induced premature S phase entry because transcription did not have the time needed to reach the end of the transcription units. To test this hypothesis, we used 5,6-dichloro-1-β -d-ribofuranosylbenzimidazole (DRB) to inhibit transcription elongation for the first 5, 7 or 9 h of G1 in cells with normal levels of cyclin E. The DRB treatment did not decrease the length of G1, but it reduced the time during which transcription was active in G1 (Extended Data Fig. 4c-f) , and, consistent with our hypothesis, it led to firing of intragenic origins at the same genomic positions as the Oi origins ( Fig. 2d-f ).
Inducible activation of the proto-oncogene MYC in U2OS cells led to a similar shortening of the G1 phase and firing of intragenic Oi origins, many of which overlapped with the cyclin E-induced Oi origins (Extended Data Fig. 5 ). Myc activation affected transcription more broadly than cyclin E overexpression, but, as observed in the cyclin E system, constitutive and Oi origins were associated with sites of low and high transcriptional activity, respectively, highlighting the mechanistic similarities between cyclin E and Myc-induced intragenic origin firing (Extended Data Fig. 5i-k) .
HeLa cells, a well-characterized cancer cell line, entered S phase with similar kinetics to those of U2OS cells overexpressing cyclin E. Analysis of DNA replication initiation at 6 and 14 h after mitotic shakeoff revealed firing of the same Oi origins as characterized in the U2OS cell systems, for the cells with the shortest G1 phases (Extended Data To determine whether Oi origin firing could lead to DNA replication stress, we compared fork progression from constitutive and Oi origins. To monitor constitutive origins, cells expressing normal or high levels of cyclin E were arrested with hydroxyurea for 14 and 10 h after mitotic exit, respectively, and then released from the hydroxyurea block for various time periods (30 min-2.5 h) with EdU being added for the last 30 min before harvesting the cells (EdUseq-HU/release) ( Fig. 3a ). There was robust incorporation of EdU label around the constitutive origins at all release time points examined. Although fork progression from constitutive origins was slower in cyclin E-overexpressing cells, which has been previously attributed to the increased number of origins 6, 7 , there was no evidence of fork collapse (Fig. 3a, b ). To monitor Oi origins, we repeated the experiment with cyclin E-overexpressing cells that were arrested with hydroxyurea for only 6 h after mitotic exit, a time point at which Oi origins have fired with high efficiency. Notably, the Oi origins failed to recover from the hydroxyurea block, indicating fork collapse, whereas in the same cells forks from constitutive origins did not collapse (Fig. 3c, d and Supplementary Table 4 ). The degree of fork collapse correlated with the level of transcription at the sites of Oi origins (Fig. 3d) , and treating the cells with the transcription inhibitor DRB as the cells were entering S phase rescued fork collapse (Fig. 3e , f and Supplementary Table 4 ), suggesting that replication-transcription conflicts were the underlying cause. This conclusion was further supported by analysis of cells with normal levels of cyclin E, in which Oi origins were induced to fire by inhibiting transcription in early G1 (Extended Data Fig. 8 ).
We next examined whether fork collapse at Oi origins led to the formation of DNA double-stranded breaks (DSBs). We studied unsynchronized cells expressing normal or high levels of cyclin E in the absence of exogenous replication stress-inducing agents, such as hydroxyurea. DNA DSBs leading to translocations with a CRISPR-Cas9-induced site-specific DNA DSB were identified using the linear amplification-mediated high-throughput genome-wide translocation sequencing (LAM-HTGTS) assay 23 . Translocations were mapped to Oi origins and also, more broadly, to the genomic domains replicated from these origins (Oi replication initiation domains), which we identified from the replication initiation profiles of cells that were not treated with hydroxyurea ( Fig. 1h ). Translocation breakpoints were enriched at Oi origins specifically in cyclin E-overexpressing cells ( Fig. 4a, b ). The effect was dependent on the level of transcription, as only Oi origins at highly transcribed loci were significantly associated with translocations ( Fig. 4b) . Similarly, the percentage of translocations mapping to Oi replication initiation domains increased significantly upon cyclin E overexpression, and the identified translocations mapped preferentially to those domains with mid or high levels of transcription ( Fig. 4c and Extended Data Fig. 9a ). Similar findings were obtained by examining breakpoints of previously identified gross chromosomal rearrangements (amplifications and deletions) in the same cyclin E-inducible cells 14 and in a large cohort of human cancers 4 ( Fig. 4d -f, Extended Data Fig. 9b-d and Supplementary Table 5 ).
The genome-wide replication initiation and transcription profiles described here provide new insights into how oncogenes induce DNA replication stress. We observed that oncogenes induce the firing of novel replication origins, which, unlike the constitutive origins, are intragenic and give rise to replication forks that are prone to collapse. Therefore, oncogene-induced DNA replication stress does not involve all replisomes, but the subset derived from the novel, intragenic origins. This latter subset was also associated with a higher frequency of genomic rearrangements in cancer. Our study did not interrogate the late-replicating part of the genome, which is where most common fragile sites map [24] [25] [26] . Nevertheless, more chromosomal rearrangements in human cancers map to early-than to late-replicating genomic domains (Extended Data Fig. 9e ), and early replicating fragile sites have also been identified 27 . The collapse of forks initiating from intragenic, oncogene-induced origins could be attributed to replicationtranscription conflicts, whereas forks from intergenic, constitutive origins did not collapse, even when replicating highly transcribed genes. This difference in behaviour may relate to the fact that head-on replication-transcription collisions, the most damaging type 28 , cannot Rearr. by Tx level (pan-cancer) P < 10 -100 P < 10 -100 P < 10 -100 P < 10 -100 P < 10 -100
Rearr. by cancer type P < 10 -94 P < 10 -100 P < 10 -100 P < 10 -100 P < 10 -100 P < 10 -100 P < 10 -100 P < 10 -100 P < 10 -61 P < 10 -100 Letter reSeArCH be prevented when origins fire within genes. However, for constitutive origins, which are intergenic, head-on collisions can be avoided by a genomic organization, including replication fork barriers, that favours co-directionality of replication with transcription 29, 30 . Alternatively, forks might be particularly sensitive to replication-transcription conflicts shortly after origin firing (for example, before lagging strand synthesis has converted the initial origin bubble to double-stranded DNA daughter molecules), which would explain why forks from intragenic origins are prone to collapse.
Our study also helps to explain how oncogenes induce firing of intragenic origins. We observed that transcription suppresses origin firing from within genes. In normal cell cycles, the length of G1 is sufficient for transcription to inactivate origins across the entire length of genes. However, oncogenes greatly reduce the length of G1 and therefore leave insufficient time for transcription to inactivate all intragenic origins ( Fig. 4g and Extended Data Fig. 10 ). This concept of transcription erasing intragenic origins fits with the well-known observation that the largest genes in the human genome are late replicating, which would, in principle, provide more time for transcription to reach the 3′ end of these genes before they initiate replication. This mechanism also helps to reconcile how shortening of the G1 phase, a typical outcome of oncogene activation, leads to aberrant origin firing and DNA replication stress.

MethOdS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Cell culture. U2OS cells inducibly overexpressing cyclin E (U2OS-CE; from J. Bartek), were maintained in Dulbecco's modified Eagle's medium (Invitrogen, Cat. No. 11960), supplemented with 10% fetal bovine serum (FBS; Invitrogen, Cat. No. 10500), penicillin/streptomycin/glutamine (Invitrogen, Cat. No. 10378-016), G418 400 μ g/ml (Invitrogen, Cat. No. 10131-027), puromycin 1 μ g/ml (Sigma, Cat. No. P8833) and tetracycline 2 μ g/ml (Sigma, Cat. No. T7660). At the indicated number of days before the experiment, the cells were split into two aliquots. One aliquot was cultured in medium without tetracycline to induce cyclin E overexpression (OE cells) and the other in medium with 1 μ g/ml doxycycline (Sigma, Cat. No. D3447) to maintain low levels of ectopic cyclin E expression (NE cells). U2OS cells inducibly activating Myc (U2OS-MycER; from M. Eilers) were maintained in Dulbecco's modified Eagle's medium without phenol red (Invitrogen, Cat. No. 31053), supplemented with 10% FBS and penicillin/streptomycin/ glutamine. At the indicated number of days before the experiment, MycER activity was induced with 100 nM 4-hydroxytamoxifen (4-OHT; Sigma, Cat. No. H7904) dissolved in methanol. HeLa cells were purchased from the American Type Culture Collection (ATCC) and were maintained in Dulbecco's modified Eagle's medium, supplemented with 10% FBS and penicillin/streptomycin/glutamine. hTERT-RPE1 retinal pigment epithelial cells were purchased from the ATCC and were cultured in Dulbecco's Modified Eagle's Medium/Ham's F-12 (Invitrogen, Cat. No. 12634-010), supplemented with 10% FBS, penicillin/streptomycin/glutamine and hygromycin B (Sigma, Cat. No. H3274). All cell lines were identified by karyotyping and high-throughput genome sequencing and were routinely tested for the absence of mycoplasma contamination. Antibodies, fluorescence and immunoblotting. Antibodies specific for cyclin E (Novocastra, Cat. No. NCL-CYCLINE), α -actinin (Millipore, Cat. No. 05-384) and c-Myc (Cell Signalling, Cat. No. 5605) were obtained from the indicated vendors. Immunofluorescence and immunoblotting were performed as previously described 14 . EU staining was performed using the Click-iT RNA Alexa Fluor 488 Imaging Kit (ThermoFisher, Cat. No. C10329) according to the manufacturer's instructions. Cell nuclei were counterstained with DAPI. REPLIseq. U2OS-CE cells were cultured for 1, 2 or 7 days with or without doxycycline. The day before the experiment, the cells were re-seeded in order to obtain 70% confluency the following day. EdU (Invitrogen, Cat. No. A10044) was added at a concentration of 25 μ M for 30 min to the asynchronously growing cells. The cells were then collected, fixed in 90% methanol overnight and permeabilized with 0.2% triton-X in PBS. EdU was coupled to a cleavable biotin linker (Azide-PEG(3+ 3)-S-S-biotin) (Jena Biosciences, Cat. No. CLK-A2112-10) using the Click-it Kit (Invitrogen Cat. No. C-10420). Genomic DNA was stained with propidium iodide (Sigma, Cat. No. 81845) in combination with RNase (Roche, Cat. No. 11119915001) and the cells were then sorted into three cell cycle populations according to DNA content using a MoFlo Astrios flow sorter (Beckman Coulter) at the Flow Cytometry platform of the Medical Faculty of the University of Geneva. DNA isolated from the sorted cells was purified by phenol-chloroform extraction and ethanol precipitation and subjected to EdU-labelled DNA isolation (see 'EdU-labelled DNA isolation and sequencing' below). The REPLIseq samples are listed in Supplementary Table 6 . Flow cytometry assessment of S phase entry. U2OS-CE cells were cultured with or without doxycycline for two days, and U2OS-MycER cells were cultured with or without 4OHT for three days. Cells were treated with 100 ng/ml nocodazole (Tocris, Cat. No. 1228) for 8 h to induce mitotic arrest, except for RPE1 cells, which were treated with 200 ng/ml nocodazole. Mitotic cells were isolated by shake-off, washed with PBS, released in warm medium containing 25 μ M EdU (Invitrogen, Cat. No. A10044) and then collected every two hours and fixed with 90% methanol overnight. The cells were prepared for flow cytometry using the Click-it Kit (Invitrogen Cat. No. C-10420) according to the manufacturer's instructions. The genomic DNA was stained with propidium iodide (Sigma, Cat. No. 81845) in combination with RNase (Roche, Cat. No. 11119915001). EdU-DNA content profiles were then acquired by flow cytometry (Gallios, Beckman Coulter) to assess the percentage of cells that entered S phase in each condition at each time point. EdUseq. U2OS-CE cells were cultured with or without doxycycline for two days and U2OS-MycER cells were cultured with or without 4OHT for three days before being exposed to 100 ng/ml nocodazole (Tocris, Cat. No. 1228) for 8 h to induce mitotic arrest. HeLa and RPE1 cells were treated with 100 ng/ml or 200 ng/ml nocodazole, respectively, for 8 h. Cells in mitosis were isolated by shake-off, washed with PBS, released in warm medium containing 2 mM hydroxyurea (Sigma, Cat. No. H8627) and 25 μ M EdU (Invitrogen, Cat. No. A10044). When indicated, DRB (Sigma, Cat. No. D1916; 75 μ M), mimosine (Sigma, Cat. No. M0253; 1 mM) or aphidicolin (Sigma, Cat. No. A0781; 1 μ M) were also added to the tissue culture medium. The cells were then collected at the indicated time points and fixed with 90% methanol overnight. The EdUseq-HU samples are listed in Supplementary  Table 7 .
In a second series of experiments (EdUseq-noHU), after mitotic shake-off, the cells were released in medium without hydroxyurea. EdU (25 μ M) was added directly to the medium or one hour before the cells were collected, as indicated. The EdUseq-noHU samples are listed in Supplementary Table 8 .
In a third series of experiments (EdUseq-HU/release), after mitotic shake-off, the cells were released in medium containing hydroxyurea but not EdU. After the indicated time of incubation, hydroxyurea was removed and the cells were released in warm medium. EdU (25 μ M) was added 30 min before the cells were collected, and the cells were then fixed with 90% methanol overnight. To inhibit transcription elongation, DRB was added at 75 μ M to the cells for the indicated time points. The EdUseq-HU/release samples are listed in Supplementary Table 9 .
For all three series of EdUseq experiments, after fixing, the cells were permeabilized with 0.2% triton-X in PBS. EdU was coupled to a cleavable biotin-azide linker (Azide-PEG(3+ 3)-S-S-biotin) (Jena Biosciences, Cat. No. CLK-A2112-10) using the reagents of the Click-it Kit (Invitrogen, Cat. No. C-10424). The DNA was then purified by phenol-chloroform extraction and ethanol precipitation and subjected to EdU-labelled DNA isolation (see 'EdU-labelled DNA isolation and sequencing' below). EdU-labelled DNA isolation and sequencing. Genomic DNA was sonicated to a size range of 100-500 bp with a bioruptor sonicator (Diagenode). EdU-labelled DNA fragments were then isolated using Dynabeads MyOne streptavidin C1 (Invitrogen, Cat. No. 65001) according to the manufacturer's instructions with minor modifications. In brief, for each sample, the beads were washed three times with Binding and Washing Buffer 1× (5 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 1 M NaCL, 0.5% Tween-20) using a magnet. After washing, the beads were resuspended to twice the original volume with Binding and Washing Buffer 2×, mixed with an equal volume of sonicated EdU-labelled DNA and incubated for 15 min on a rotating wheel at room temperature. The beads were then washed three times with Binding and Washing Buffer 1× and once with TE (10 mM Tris-HCl pH 8, 1 mM EDTA) using the magnet. The EdU-labelled DNA was eluted by incubating the streptavidin beads with 2% β -mercaptoethanol (Sigma, Cat. No. M6250) for 1 h at room temperature. The eluted DNA for REPLIseq was purified by phenol-chloroform extraction followed by ethanol precipitation before being prepared for Illumina single-end sequencing. The eluted DNA for EdUseq was directly used for library preparation. The libraries were made by the Genomics Platform of the University of Geneva using the TruSeq ChIP Sample Prep Kit (Illumina, Cat. No. IP-202-1012). One hundred base pair single-end read sequencing reactions were then performed on an Illumina Hi-Seq 2500 or Illumina Hi-Seq 4000 sequencer.
In order to compare the levels of EdU incorporation among the various REPLIseq samples, the EdU-labelled genomic DNA isolated from NE and OE 2d (2 days after tetracycline withdrawal) U2OS-CE cells was spiked with a constant amount of EdU-labelled DNA prepared from mouse embryo fibroblasts (MEFs) before the EdU-labelled DNA was isolated. This permitted calibration of the amount of EdU incorporation per cell among the various samples, by dividing the number of sequencing reads of EdU-labelled human DNA by the number of reads of EdUlabelled mouse DNA and by the fraction of EdU-positive cells in that sample. EUseq. For sequencing of newly synthesized transcripts (EUseq), cells were synchronized in mitosis and released in 2 mM hydroxyurea, as in EdUseq. For the series of experiments for which transcription elongation was inhibited, DRB was added at 75 μ M to the cells for the indicated time periods. EU (5-ethynyl-uridine, Jena Biosciences, Cat. No. CLK-N002-10) was added to the cells at a concentration of 0.5 mM 30 min before the cells were collected at the indicated time points. RNA was then extracted and purified using TRIzol (Invitrogen, Cat. No. 15596) and isopropanol precipitation. Nascent RNA was biotinylated and purified using the reagents of the Click-iT Nascent RNA Capture Kit (Invitrogen, Cat. No. C-10365) according to the manufacturer's instructions, but replacing the biotin-azide from the kit with cleavable biotin-azide (Azide-PEG(3+ 3)-S-S-biotin) (Jena Biosciences, Cat. No. CLK-A2112-10). The EU-labelled RNA was then isolated using Dynabeads MyOne streptavidin C1 (Invitrogen, Cat. No. 65001) according to the manufacturer's instructions with minor modifications. In brief, the beads (50 μ l beads per microgram RNA) were washed three times with Binding and Washing Buffer 1× (5 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 1 M NaCL, 0.5% Tween-20) followed by two 2 min washes in solution A (0.1 M NaOH, 0.05 M NaCl) and two washes in solution B (0.1 M NaCl) using a magnet. After washing, the beads were resuspended to twice the original volume with Binding and Washing Buffer 2× , and mixed with an equal volume of EU-labelled RNA. The RNA had been previously heated at 70 °C and placed back on ice to remove secondary structures. The mix was incubated for 30 min on a rotating wheel at room temperature. The beads were then washed three times with Binding and Washing Buffer 1× and Letter reSeArCH once with RNase free-water using the magnet. The EU-labelled RNA was finally eluted by incubating the streptavidin beads with 2% β -mercaptoethanol (Sigma, Cat. No. M6250) for 1 h at room temperature. Sequencing libraries were prepared by the Genomics Platform of the University of Geneva using TruSeq Stranded Total RNA with Ribo-Zero Gold (Illumina, Cat. No. RS-122-2301) and omitting the ribo-depletion step. One hundred base pair single-end read sequencing reactions were performed on an Illumina Hi-Seq 2500 or Illumina Hi-Seq 4000 sequencer. The EUseq samples are listed in Supplementary Table 10 . LAM-HTGTS. Translocations were detected in NE and OE U2OS-CE cells using LAM-HTGTS as previously described 23 , omitting the optional enzyme blocking step. DSBs were induced at a bait site located in an early replicating intergenic region of chromosome 9, using a guide RNA (gRNA-chr9: CACCGAGGAAACTGAGTCACAGGCT, chr9: 21685208-21685227) in combination with the Cas9 nuclease (Addgene, Cat. No. 48138, pX458, pSpCas9(BB)-2A-GFP). Cells with normal expression of cyclin E and cells in which cyclin E overexpression had been induced for three days were transfected with the Cas9:gRNA-chr9 plasmid and collected two days after transfection for the LAM-HTGTS procedure. Non-transfected cells were also collected as a negative control sample. The primers were designed as follows 23 :
Bio-primer-chr9: /5-biotin/AAGTCTCTCCAGCCAAGAACAG I5-Nested-chr9: ACACTCTTTCCCTACACGACGCTCTTCCGATCT-BARCODE-GGAAAGGGTAGTGGGAGGTAGAAAGC Paired-end read sequencing reactions (100 bp) were performed on an Illumina Hi-Seq 2500 sequencer. The LAM-HTGTS samples are listed in Supplementary  Table 11 . Sequence alignment and calculation of sigma values. Sequence reads were aligned to the masked human genome assembly (GRCh37/hg19) using the Burrows-Wheeler aligner algorithm 31 , retaining only the reads with the highest quality scores. Custom Perl scripts were then developed to process the data for analysis and visualization. First, the chromosomes were split into 10-kb bins and the sequence reads were assigned to their respective bin. Then, to correct for sequencing bias across the genome (reflecting experimental biases and differences in the number of masked base pairs per bin), the number of sequence reads per bin (SeqRpB) was normalized using the number of reads previously obtained by sequencing genomic DNA from the same cells (referred to as adjust sample and representing a total of more than 342 million reads) 14 using the formula NormSeqRpB = SeqRpB/AdjRpB, where NormSeqRpB stands for normalized sequence reads per bin and AdjRpB for adjust reads per bin. Genomic bins were retained for further analysis only if the number of adjust reads per bin was within the range of 25-10,000 (average 1,241 AdjRpB), resulting in a human genome assembly of 275,491 genomic bins corresponding to chromosomes 1-22 and chromosome X (as U2OS cells were derived from a female patient). After normalization of the sequence reads, standard deviation values were calculated for each genomic bin. This permitted the calculation of sigma (σ) values for each genomic bin according to the formula σ = (NormSeqRpB − mean background NormSeqRpB)/s.d. For all samples, the mean background NormSeqRpB value was much smaller than the peak NormSeqRpB values, but was, nevertheless, subtracted to lead to more accurate sigma value estimates. The sigma values were then used to plot the data and perform all subsequent analyses, thus, allowing comparison of samples with different background levels and providing a quick way to ascertain whether the observed peaks were statistically significant.
To calculate the genome-wide, mean background NormSeqRpB value, we used a differential function to determine the fraction of the genome with background signal (that is, the genomic bins lacking true signal); the mean NormSeqRpB value of these genomic bins corresponded to the genome-wide, background NormSeqRpB mean value. NormSeqRpB SDs were calculated for each genomic bin. First, the fraction of the genome with background signal was sorted into 200 equal subfractions, according to the number of AdjRpB, with each subfraction corresponding to a range of AdjRpB, spanning the entire possible range of 25-10,000. The NormSeqRpB values of these subfractions were then used to calculate background NormSeqRpB s.d. values for each subfraction. The s.d. values of all the subfractions were plotted against the mean AdjRpB of their corresponding subfractions, resulting in a power regression curve of the type s.d. of background NormSeqRpB of a subfraction = a × (mean AdjRpB of the subfraction) b , where a and b are constants. For all samples, the power regression equations fit the data with coefficients of determination (R 2 ) greater than 0.9. The determined values of the a and b constants were then used to calculate an s.d. for each genomic bin (including the bins with true signal) from its AdjRpB. For the EUseq data, most background genomic bins had NormSeqRpB values equal to zero; thus, for these samples, we calculated relative rather than absolute s.d. and sigma values.
The EdUseq-HU data sets were plotted after subtracting the mean background NormSeqRpB value; all other data sets (including the EdUseq-HU/release and EdUseq-noHU data sets) were plotted without background subtraction.
The computer codes to perform the analyses described above are included in the Supplementary Information.
Identification and classification of replication origins from EdUseq-HU data.
A peak-finding algorithm searched for local maxima. Each local maximum was then evaluated on the basis of its sigma value and shape and retained as a peak, only if its values exceeded predefined sigma and shape thresholds. One peak list comprised the peaks identified in the EdUseq-HU 4 h OE data set, while a second list comprised the peaks identified in the 14 h NE data set. The peaks that had been identified in both data sets at exactly the same genomic bin were then used to calculate an adjustment factor (AdjFactor) using the formula AdjFactor = sum of sigma values of 14 h NE shared peaks/sum of sigma values of 4 h OE shared peaks.
The sigma values of all genomic bins of the 4 h OE sample were then multiplied by this adjustment factor. A new peak list was then generated by including all peaks from both data sets, irrespective of whether the peak was present in both samples or only in one sample. Peaks that mapped to adjacent genomic bins (that is, within 10 kb) in the two data sets were considered to correspond to a single origin and assigned to the genomic bin with the highest sigma value (original sigma for the 14 h NE data set and adjusted sigma for the 4 h OE data set).
For every peak in the merged peak list (irrespective of whether the peak had been identified in the NE or OE or both samples), the sigma values at its genomic position in the NE and OE samples (adjusted sigma for the OE sample) were obtained and compared. If the ratio of the OE:NE sigma values was greater than 4, then the origin was considered as oncogene-induced (Oi); otherwise, if the ratio was greater than 2, but lower than 4, the origin was considered as Oi2. All other origins were considered to be constitutive (CN). The assignment of origins into the CN, Oi2 and Oi classes facilitated comparisons among the various samples using power regression curves of the type σ of OE sample = a × (σ of NE sample) b , where a and b are constants.
The power curve was converted to a linear regression curve: log 2 (σ of OE sample) = log 2 (a) + b × log 2 (σ of NE sample), to facilitate plotting of the data as scatter plots and calculation of coefficients of determination (R 2 ). A similar analysis was performed for cells with inducible activation of Myc and for the EUseq data. Assignment of replication timing domains. The early, mid and late S phase REPLIseq data were calibrated by spiking the samples with a known quantity of mouse genomic EdU-labelled DNA. After assignment of the REPLIseq reads to genomic bins and adjustment of the number of reads, as described above for the EdUseq data, the number of early, mid and late S phase reads were compared for each genomic bin. If one sample (early, mid or late S) accounted for more than half of the total reads for a specific genomic bin, then that bin was assigned to the corresponding replication timing domain. The assignment of replication timing domains used for further analysis was based on the NE samples, which showed sharp REPLIseq profiles. Assignment of genic and intergenic domains. RefSeq gene annotations were used to compile a list of all human protein-coding genes and their position in the genome. Genomic bins were defined as being purely genic, if they mapped entirely within protein-coding genes; purely intergenic, if the bins mapped entirely within intergenic sequences; or mixed, if they encompassed both genic and intergenic sequences. The analysis of the distribution of origins in the genome considered the pure intergenic and mixed genic/intergenic bins as intergenic and the pure genic bins as genic. Determination of average EUseq and EdUseq signals along large genes. EUseq relative sigma (rσ) values were converted to a log 2 scale for all the subsequent analysis described in this section. Genes over 200 kb in size were identified in the early-and mid-replicating parts of the genome using RefSeq gene annotations and the average EUseq log 2 (rσ) value across the lengths of these genes 14 h after mitotic exit was used to classify the genes according to their level of transcription (high, upper tercile; medium, middle tercile; and low, lower tercile). EUseq data sets corresponding to different times after exit from mitosis were then adjusted relative to each other by comparing the sum of their EUseq log 2 (rσ) values corresponding to the first five genomic bins of each large gene. Then, average EUseq log 2 (rσ) values were plotted as a function of the distance from the 5′ end of the gene. The five most 3′ genomic bins of each gene were trimmed and not included in the analysis, as in some genes EdUseq signal from origins located in intergenic bins adjacent to the gene was spilling over into the 3′ end of the gene. Average EdUseq values (linear σ) were also plotted along gene length. Sigma values of the OE samples were adjusted relative to the sigma values of the NE samples. Calculation of fork speed. Fork speeds were calculated from EdUseq data sets of NE and OE cells treated with hydroxyurea for 14 and 10 h after mitotic exit, respectively, and EdUseq-HU/release data sets for NE and OE cells at 90 and 150 min release time points. The 10% tallest constitutive peaks in the genome were initially selected. Then, the peak finding algorithm described above was used to identify peaks in the EdUseq-HU/release 90-and 150-min data sets on either side of the origins. The positions of peaks identified with high confidence in the release data sets, were then used to calculate the distance forks travelled between the 90-and 150-min time points. The same list of origins (n = 325) was examined in the NE and OE samples. Analysis of fork collapse. To study fork collapse, a set of origins was selected for which fork progression could be monitored without interference from neighbouring origins. The criterion for selection was that within 20 genomic bins of the position of the origin being examined, there was no other origin that had a sigma value equal to or greater than the sigma value of the origin being selected. Selected origins were further classified according to their transcription level (upper and lower terciles, as defined above) at the time the cells were released from the hydroxyurea arrest. The number of origins thus selected in each category was: CN-high transcription, 67; CN-low transcription, 233; Oi2-high transcription, 39; Oi2-low transcription, 55; Oi-high transcription, 57; Oi-low transcription, 47. Adjusted averages (relative to the no release data) of EdUseq and EdUseq-HU/ release data sets were then calculated for each origin category. A similar analysis, using the same set of origins, was performed for cells treated with DRB.
Identification of translocations by LAM-HTGTS and mapping to Oi origins.
Paired-end sequencing reads were aligned independently to the masked human genome assembly (GRCh37/hg19) using the Burrows-Wheeler aligner mem algorithm 31 and duplicate reads were filtered out. Read pairs corresponding to junctions between the bait site and another genomic region and containing the junction sequence in one of the two reads were retained. Furthermore, because DNA double-strand ends induced by fork collapse in S phase will probably be repaired by microhomology-mediated end joining, paired ends were further required to have a 2-5-base pair microhomology junction. Translocation breakpoints identified by LAM-HTGTS in OE and NE cells were then mapped to Oi origins. A subset of all Oi origins was used for this analysis, requiring that within 10 genomic bins of the position of the origin being examined, there was no other origin that had a sigma value equal to or greater than twice the sigma value of the origin being selected. Selected origins were further classified according to their transcription level (upper and lower terciles, as defined above) 14 h after the cells were released from hydroxyurea arrest. The number of selected origins were: Oi-high transcription, 108; Oi-low transcription, 62. The number of translocations mapping to each genomic bin was divided by the number of origins (Oi-high transcription or Oi-low transcription); for the translocations identified in the NE cells, the average number of translocations per bin was further adjusted by the ratio of the total number of LAM-HTGTS in the NE and OE samples to allow comparisons between the samples. A permutation analysis was performed to evaluate whether the observed differences between the number of identified translocations mapping to Oi origins in the OE and NE samples were statistically significant.
Identification of Oi replication initiation domains (OiRDs).
The sigma values of the EdUseq-noHU data sets from OE cells incubated for the first 3 h after mitotic exit with EdU and from NE cells incubated for the first 10 h after mitotic exit with EdU ( Fig. 1h ) were converted to log 2 values. A linear regression curve of the values corresponding to the genomic positions of the Oi2 origins in an OE:NE plot was then used to assign all genomic bins that had EdUseq signal above background to Oi replication initiation domain (OiRD) bins, using as criterion that the log 2 OE:NE sigma values of the bin were more than 0.6 units to the left of the Oi2 curve.
Mapping of translocations and genomic rearrangement breakpoints to
OiRDs. The translocation breakpoints identified by LAM-HTGTS (n = 16,629 and n = 10,735 for NE and OE cells, respectively), the breakpoints of genomic rearrangements (n = 136, Extended Data Table 2 ; derived from 81 rearrangements-for rearrangements less than 100 kb long, a single breakpoint was calculated corresponding to the centre position of the rearrangement) identified by us in the same U2OS cells overexpressing cyclin E for three weeks 14 and the breakpoints of rearrangements (deletions and amplifications, n = 490,711) present in a cohort of ~ 5,000 human cancers 4 were mapped to the Oi replication initiation domains (OiRDs). The frequency of OiRDs in the entire genome served as reference. The analysis was performed in the context of the entire genome ( Fig. 4c-f ) and also for only the early S replicating part of the genome (Extended Data Fig. 9a-d) , where about half of the OiRDs mapped. Statistical comparisons for the LAM-HTGTS and U2OS breakpoint rearrangement data were performed using random permutations; for the TCGA data, the observed and genomic frequencies were used to calculate z-scores, from which P values were determined. Code availability. Computer codes and data files used to process and plot the data are available as Supplementary Information. Other codes are available from the corresponding author upon request. Data availability. The fastq sequencing data and associated information described in this study have been deposited in the Sequence Read Archive (SRA) as BioProject PRJNA397123.
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Extended Data Figure 1 | Experimental setup to study S phase entry and DNA replication initiation. a, Cyclin E protein levels, as determined by immunoblotting, in NE and OE cells (2.5 days after tetracycline withdrawal). Actinin serves as a loading control. This is a representative example of more than ten independent replicates. b, Experimental outline of the protocol used to monitor S phase entry by flow cytometry and of the EdUseq protocols: EdUseq-HU, EdUseq-noHU and EdUseq-HU/release. * EdU was added 30 min before harvesting the cells. c, Flow cytometry profiles of NE and OE cells after mitotic shake-off (0 h) and 14 and 10 h later, respectively, after the cells had been released in medium containing hydroxyurea and EdU. 2C and 4C, DNA content of G1 and G2 cells, respectively. This is a representative example of more than ten independent replicates. d, DNA content versus EdU incorporation flow cytometry plots of NE and OE cells. EdU-positive NE and OE cells were gated blue and red, respectively. 2C and 4C, DNA content of G1 and G2 cells, respectively. The gating strategy for these data is shown in Supplementary Fig. 1 . e, Transcription (EUseq) levels (median) in NE (light grey) and OE (dark grey) cells at sites of constitutive and oncogene-induced origins, refined at 1 kb resolution, at various time points after mitotic shake-off. Origins mapping to genic or intergenic genomic bins were plotted separately. f, Scatter plots of EdUseq-noHU sigma values (log 2 ) at all origins (CN, purple; Oi2, pink; Oi, red) at 10 kb resolution for NE versus OE cells not treated with hydroxyurea ( Fig. 1h ). EdU was present during the indicated time periods.
Extended Data Figure 4 | Further characterization of transcription profiles and effects of DRB. a, Genome-wide comparison (all genomic bins) of newly synthesized transcripts (EUseq) in NE versus OE cells at the indicated time points after mitotic shake-off. The two genomic bins mapping to CCNE1 are red. b, List of early and mid S large genes along which replication initiation and transcription profiles were plotted in Fig. 2d . For each gene, the association with a common fragile site (CFS) is indicated 24 . c, Inhibition of transcription by DRB. EU incorporation was monitored by fluorescence microscopy in control (no DRB), DRBtreated (9 h), and DRB-treated (9 h) and released (5 h) cells. The nuclei of the cells were counterstained with DAPI. d, DNA content versus EdU incorporation flow cytometry plots of NE cells 14 h after mitotic shakeoff. The cells were treated with DRB for the indicated times. EdU-positive NE cells were gated in blue. 2C and 4C, DNA content of G1 and G2 cells, respectively. e, Newly synthesized transcript profiles (EUseq) at a representative genomic region in NE cells treated with DRB for 9 h after mitotic shake-off and then released for 30 or 120 min (release 30 min, dark grey; release 120 min, light grey; overlap: colour; direction of transcription: green, forward (forw); red, reverse (rev); yellow, bidirectional (bidir)). The red arrow indicates the transcription of the gene harbouring oncogeneinduced origins at our example locus on chromosome 7 and the green arrow indicates another large gene in this locus. RT domain and Ge/iG annotations are as in Fig. 1b . f, Average transcription (EUseq, log 2 rσ) in NE cells treated with DRB for 9 h after mitotic-shake-off and then released for 30, 120 or 240 min, along the length of large genes (> 0.35 Mb for early S and > 0.65 Mb for mid S genes). The genes are grouped according to replication timing (RT; early, mid S) and level of transcription (high Tx, upper tercile; mid Tx, middle tercile). # Ge, number of genes averaged at each position. Oi2 and Oi origins in OM and NM cells according to gene annotation in all replication timing domains (all-RT) or only in the early S phase replicating domains (E-RT). h, Relative adjusted sigma ratios of replication origins identified in NE, NM, OE or OM cells. Left, number of origins identified in NE or NM cells grouped according to their relative height ratios between these two cell lines. Right, number of Oi origins identified in OE or OM cells grouped according to their level of induction relative to the NE and NM cells, respectively. i, Newly synthesized transcript profiles (EUseq) at a representative genomic region in OM and NM cells 10 and 14 h after mitotic shake-off, respectively (NM: light grey; OM: dark grey; overlap: green, forward (forw); red, reverse (rev); yellow, bidirectional (bidir) direction of transcription). RT domains and gene annotations are as in c. j, Genome-wide comparison (all genomic bins) of transcription in OM versus NM cells 10 and 14 h after mitotic shake-off, respectively. k, Median transcription (EUseq) levels in NM (light grey) and OM (dark grey) cells at constitutive and oncogene-induced origins mapping to genic (Ge) or intergenic (iG) genomic bins at 14 and 10 h after mitotic shake-off, respectively.
Extended Data Figure 7 | Replication initiation and transcription profiles at selected genomic loci. a, Replication initiation (EdUseq-HU) profiles at three genomic loci in different cells lines, from top to bottom: OE versus NE cells, collected 6 and 14 h after mitotic shake-off, respectively; OM versus NM cells, collected 6 and 14 h after mitotic shakeoff, respectively; HeLa cells collected at 6 versus 14 h after mitotic shakeoff; and RPE1 cells collected 14 h after mitotic shake-off. Peak heights are represented as sigma values. RT domains and gene annotations are as in Fig. 1b . Bin resolution, 10 kb; ruler scale, 100 kb. The green arrows indicate the direction of transcription of the example gene of each locus harbouring oncogene-induced origins. b, Replication initiation (EdUseq-HU) profiles of control (noDRB) and DRB-treated (0-9 h) NE cells collected 14 h after mitotic shake-off. The same genomic loci as in a are shown, focusing on the genes harbouring the oncogene-induced origins. RT domains and gene annotations are as in a. c, Newly synthesized transcript profiles (EUseq) of NE cells, 2 and 14 h after mitotic shake-off (2 h, light green; 14 h, grey; overlap, dark green) shown only for the example genes harbouring the oncogene-induced origins shown in a (green arrows). RT domains and gene annotations are as in a.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons Test values indicating whether an effect is present Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
The BWA software was used for sequencing read alignment. A description of custom codes is provided in the Method section and codes used to process and graph the data are available as Supplementary Data.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
No unique materials were used.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
A full description of the antibodies used (Cyclin E (Novocastra, Cat. No. NCL-CYCLINE), α-Actinin (Millipore, Cat. No. 05-384), c-Myc (Cell Signalling, Cat. No. 5605)) is provided in the Method section. For these antibodies, validation statements for their use in WB (Cyclin E and α-Actinin) or IF (c-Myc) using human cells can be found on the manufacturer's websites. 10 . Eukaryotic cell lines a. State the source of each eukaryotic cell line used.
U2OS cyclin E cells were provided by J. Bartek laboratory, U2OS mycER cells were provided by M. Eilers laboratory and HeLa and hTERT-RPE1 cells were bought from ATCC. b. Describe the method of cell line authentication used. U2OS cyclin E cells were authenticated by SKY. For the other cell lines, we verified from the sequencing data we obtained, that the sequence read depth at each genomic position matched that of WGS data publicly available for these cell lines. c. Report whether the cell lines were tested for mycoplasma contamination.
Yes, cell lines were routinely tested for mycoplasma contamination.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used in this study.
